I agree that his hands are tied, but I don't think he is the wrong guy. This is a very very complex undertaking and I think that it probably is still not fully understood and accepted. From the CC, it appears that everything hinges on the 2nd clinic trial and subsequent paper. Remember the Alticor placeholders we had before Bender? That's what we will get if he's gone and with his new deal, he isn't going anywhere. Besides, he is deducting $35 a week from his salary to accumulate stock.